HCA Healthcare Inc. (HCA)

NYSE: HCA · USD

$418

+28.56 (+7.3%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-29 02:00 UTC. Latest published research analyzed 2026-05-13 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh HCA analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: HCA rated Strong Buy

HCA is rated Strong Buy at $426.37 versus the reconciled fair value midpoint of $647.26, implying +51.81% upside/downside. Confidence is separately disclosed at 88/100.

Fair value (mid)

$647 / share

$497 – $798

Upside to FV

+51.8%

from $418

Confidence

88/100

Moat

9/10

Read full analysis

Market cap	$94.6B
Revenue (ttm)	78B
Net income (ttm)	6.8B
EPS (ttm)	$29.9
Shares out	221.8M
P/E (trailing)	14.0x
P/E (forward)	12.9x
Dividend	$3.12 (0.75%)
Volume	2,925,403
Beta	1.13
Price target	$453	+8.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 78B
Net income (ttm): 6.8B
EPS (ttm): $29.9
P/E (trailing): 14.0x
P/E (forward): 12.9x
Market cap: $94.6B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	—	$60.23B	$64.97B	$70.60B	$75.60B	+5.8%
Gross profit	—	$23.18B	$25.58B	$28.68B	$31.37B	+7.9%
Operating income	—	$9.05B	$9.63B	$10.55B	$11.97B	+7.2%
Net income	—	$5.64B	$5.24B	$5.76B	$6.78B	+4.7%
EPS (diluted)	—	$19.15	$18.97	$22.00	$28.33	+10.3%
EBITDA	—	$13.29B	$12.72B	$13.90B	$15.60B	+4.1%
R&D	—	—	—	—	—	—
SG&A	$26.78B	$27.69B	$29.49B	$31.17B	—	+3.9%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All HCA indicators

Market & fundamental data

Available fields

279

Groups with data

Currency

USD

Showing 279 of 279 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000860730
Company name	HCA Healthcare, Inc.
Country	United States
Country code	US
Cusip	40412C101
Employees	320,000
Employees Change	4,000%
Employees Change Percent	1.27
Enterprise value	$143.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Care Facilities
Industry PE	16.6
Industry PE Fwd	15.64
Isin	US40412C1018
Last refreshed	2026-07-29
Market cap	$92.8B
Market cap category	Large-Cap
Price	$418
Price currency	USD
Rev Per Employee	243,790.63x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	8062
Symbol	HCA
Website	https://www.hcahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.37%
EV Earnings	20.95x
EV Sales Forward	1.79x
EV/EBIT	11.87x
EV/EBITDA	9.1x
EV/FCF	23.9x
EV/Sales	1.84x
FCF yield	6.46%
Forward P/E	13.63x
P/E ratio	14x
P/S ratio	1.19x
PE Ratio10 Y	12.84x
PE Ratio3 Y	14.75x
PE Ratio5 Y	13.41x
PEG ratio	1.39x
PS Forward	1.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.48%
EBITDA Margin	20.19%
FCF margin	7.69%
Gross margin	42.58%
Gross Profit	$33.2B
Gross Profit Growth	11.74%
Gross Profit Growth Q	18.77%
Gross Profit Growth3 Y	11.51%
Gross Profit Growth5 Y	8.79%
Net Income	$6.8B
Net Income Growth	14.55%
Net Income Growth Q	2.78%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	5.83%
Net Income Growth5 Y	6.61%
Pretax Margin	12.65%
Profit Margin	8.77%
Profit Per Employee	$21,375
Profitable Quarters	$65
Profitable Years	18
ROA	12.29
Roa5y	11.64
ROCE	26.28
ROIC	21.8
Roic5y	19.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	19.17%
Cagr15y	22.32%
Cagr1y	25.96%
Cagr3y	15.7%
Cagr5y	11.98%
Div CAGR10	24.21%
Div CAGR3	9.04%
Div CAGR5	16.27%
EPS Growth	25.89
EPS Growth Q	11.57
EPS Growth Quarters	5
EPS Growth Years	2
EPS Growth3 Y	13.66
EPS Growth5 Y	15.45
FCF Growth	-17.76%
FCF Growth Q	-63.61%
FCF Growth3 Y	6.73%
FCF Growth5 Y	56.44%
OCF Growth	-6.8%
OCF Growth Q	-44.54%
OCF Growth10 Y	7.48%
OCF Growth3 Y	4.23%
OCF Growth5 Y	26.95%
Revenue Growth	7.31x
Revenue Growth Q	8.73x
Revenue Growth Quarters	14x
Revenue Growth Years	16x
Revenue Growth3 Y	8.01x
Revenue Growth5 Y	6.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.27
Assets	$63.3B
Cash	$1B
Current Assets	$17.2B
Current Liabilities	$17.3B
Debt	$51.6B
Debt EBITDA	$3.27
Debt FCF	$8.6
Equity	$-3.2B
Interest Coverage	5.21
Liabilities	$66.5B
Long Term Assets	$46.1B
Long Term Liabilities	$49.1B
Net Cash	$-50.5B
Net Cash By Market Cap	$-54.48
Net Debt EBITDA	$3.21
Net Debt FCF	$8.43
Tangible Book Value	$-17.3B
Tangible Book Value Per Share	$-77.66
WACC	8

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Inventory Turnover	25.94
Net Working Capital	$5.1B
Quick ratio	0.77
Working Capital	$-122M
Working Capital Turnover	$-313

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	8.97%
Dividend Growth	8.51%
Dividend Growth Years	5%
Dividend per share	$3.12
Dividend Years	9
Dividend Yield	0.75%
Ex Div Date	2026-09-16
Last Dividend	$0.78
Payout Frequency	Quarterly
Payout Ratio	10.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	477.67%
1Y total return	25.94%
200-day SMA	457.5
3Y total return	54.91%
50-day SMA	387.9
50-day SMA vs 200-day SMA	50under200
5Y total return	76.07%
All Time High	556.5
All Time High Change	-24.86%
All Time High Date	2026-03-12
All Time Low	17.03
All Time Low Change	2,355.61%
All Time Low Date	2011-08-09
ATR	14.19
Beta	1.13
Beta1y	0.28
Beta2y	0.34
Ch YTD	-10.42
High	419.2
High52	556.5
High52 Date	2026-03-12
High52ch	-24.86%
Low	392.1
Low52	331.6
Low52 Date	2025-07-28
Low52ch	26.11%
Ma50ch	7.8%
Premarket Change Percent	2.29
Premarket Price	$399
Premarket Volume	1,808
Price vs 200-day SMA	-8.59%
RSI	62.76
RSI Monthly	53.04
RSI Weekly	47.38
Sharpe ratio	0.79x
Sortino ratio	1.33
Total Return	9.72%
Tr YTD	-10.11
Tr15y	1,953.64%
Tr1m	6.77%
Tr1w	12.09%
Tr3m	-6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	25
Analyst Count Top	12
Analyst Price Target Top	$464
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$7.41
Earnings EPS Estimate Growth	8.33
Earnings Revenue Estimate	19,371,729,736x
Earnings Revenue Estimate Growth	4.12x
Operating Income	$12.1B
Operating Income Growth	8.98
Operating Income Growth Q	3.37
Operating Income Growth3 Y	9.13
Operating Income Growth5 Y	5.11
Operating margin	15.48
Price target	$453
Price Target Change	$8.28
Price Target Change Top	$10.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	149,491,729%
Float Percent	67.39%
Net Borrowing	5,011,000,000
Shares Insiders	1.48%
Shares Institutions	62.36%
Shares Out	221,839,800
Shares Qo Q	-1.69%
Shares Yo Y	-8.97%
Short Float	3.9%
Short Ratio	3.4
Short Shares	2.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$5.6B
Adjusted OCF	10,749,000,000
Average Volume	1,782,834.95x
Bv Per Share	-29.81
CAPEX	$-5.1B
Ch10y	436.3
Ch15y	1,427.9
Ch1m	6.77
Ch1w	12.09
Ch1y	25.09
Ch3m	-6.19
Ch3y	51.34
Ch5y	68.84
Ch6m	-17.33
Change	7.33%
Change From Open	5.54
Close	389.6
Days Gap	1.69
Depreciation Amortization	3,674,000,000
Dollar Volume	1,223,374,280.6
Earnings Date	2026-07-24
Earnings Time	bmo
EBIT	$12.1B
EBITDA	$15.7B
EPS	$29.87
F Score	7
FCF	$6B
FCF EV Yield	4.18x
FCF Per Share	$27.03
Financing CF	-5,500,000,000
Fiscal Year End	December
Founded	1,968
Income Tax	$2B
Investing CF	-5,544,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-24
Last Report Date	2026-06-30
Last Split Type	Never
Last10k Filing Date	2026-02-10
Lynch Fair Value	$197
Lynch Upside	-52.79
Ma150	454.3
Ma150ch	-7.95%
Ma20	391.6
Ma20ch	6.79%
Net CF	74,000,000
Next Earnings Date	2026-10-23
Open	396.2
Optionable	Yes
P FCF Ratio	15.47
P FCF Ratio SBC	16.5
P OCF Ratio	8.34
P OCF Ratio SBC	8.63
Payment Date	2026-09-30
Position In Range	96.2
Post Close	418.2
Postmarket Change Percent	0.01
Postmarket Price	$418
Ppne	33,925,000,000
Pre Close	389.6
Price Date	2026-07-28
Price EBITDA	$5.89
Relative Volume	1.64x
Revenue	78,013,000,000x
SBC By Revenue	0.48x
Share Based Comp	375,000,000
Tax By Revenue	2.59x
Tax Rate	20.44%
Tr6m	-17.04%
Us State	Tennessee
Volume	2,925,403

Frequently asked questions

About this HCA report

What is the latest published HCA stock rating?

HCA Healthcare Inc. is shown with strong buy in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HCA analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/HCA/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for HCA?

The latest published report analyzed 2026-05-13 frames HCA around USD 497 to USD 798. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the HCA page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

HCA Healthcare Inc. (HCA)

Coverage state: Latest published research available

Generate a fresh HCA analysis

Our latest published analysis: HCA rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HCA

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All HCA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HCA

Frequently asked questions